0000950170-24-041024.txt : 20240403
0000950170-24-041024.hdr.sgml : 20240403
20240403160107
ACCESSION NUMBER: 0000950170-24-041024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PALEKAR ROHAN
CENTRAL INDEX KEY: 0001423327
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 24818584
MAIL ADDRESS:
STREET 1: 201 SPEAR STREET, THIRD FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
4
X0508
4
2024-04-01
0001785173
89bio, Inc.
ETNB
0001423327
PALEKAR ROHAN
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
true
true
false
false
Chief Executive Officer
true
Common Stock
2024-04-01
4
M
false
25000
1.93
A
511889
D
Common Stock
2024-04-01
4
S
false
52718
10.91
D
459171
D
Stock Option (Right to Buy)
1.93
2024-04-01
4
M
false
25000
0.00
D
2028-11-09
Common Stock
25000
120231
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $10.65 to $11.54. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
This option is vested in full.
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
2024-04-03